Logo Clinical Practice Review and Meta-Analysis

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Clinical Practice Review and Meta-Analysis Logo Clinical Practice Review and Meta-Analysis Logo Clinical Practice Review and Meta-Analysis

10 January 2022 : Meta-Analysis  

Antiproteinase-3 (PR3)-Antineutrophil Cytoplasmic Atibody (ANCA) as a Predictor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Meta-Analysis

Jiaojiao Gong1BCDEF, Zhihui Quan1CD, Ruiqiong Wang1B, Guotao Chen1AEG*

DOI: 10.12659/CPRM.931261

Med Sci Rev 2022; 9:e931261

Abstract

BACKGROUND: Several predictive markers are related to the relapse of antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis (AAV). However, the conclusions are not definite, especially for antiproteinase-3 ANCA (PR3-ANCA). This study evaluated the value of PR3-ANCA in predicting relapse of AAV.

MATERIAL AND METHODS: Four databases (PubMed, Embase, Web of Science, and Cochrane Library) were searched. The cohort studies that assessed the factors associated with AAV relapse were included. Study quality was assessed using the Newcastle-Ottawa scale. The hazard ratios (HR) were analyzed using fixed-effects models. The sensitivity and publication bias analysis was performed to verify the reliability of the results.

RESULTS: A total of 14 studies, including 2761 participants, were evaluated in this meta-analysis. Fixed-effects pooling showed a significant association between PR3-ANCA and the relapse of AAV (pooled HR 1.829, 95% CI 1.591-2.103) compared to MPO (myeloperoxidase)-ANCA. In addition, AAV patients with lung involvement were 1.6 times more likely to have relapse (pooled HR 1.635, 95% CI 1.324-2.064) compared to those without lung involvement. The other factors, including age, sex, kidney-limited disease, granulomatosis with polyangiitis, upper respiratory involvement, and serum creatinine, could not predict AAV relapse according to the results of fixed-effects pooling.

CONCLUSIONS: PR3-ANCA and lung involvement could be used to predict occurrence of AAV relapse.

Keywords: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Recurrence, SERPINB9 Protein, Human

Add Comment 0 Comments

Most Viewed Current Articles

12 Nov 2021 : Review article  

A Review of the Effects of Transurethral Microwave Thermotherapy (TUMT) for Lower Urinary Tract Symptoms (L...

DOI :10.12659/CPRM.934690

Clin Prac Rev Met 2021; 8:e934690

10 Jan 2022 : Meta-Analysis  

Antiproteinase-3 (PR3)-Antineutrophil Cytoplasmic Atibody (ANCA) as a Predictor for Relapse in Antineutroph...

DOI :10.12659/CPRM.931261

Clin Prac Rev Met 2022; 9:e931261

21 Mar 2023 : Meta-Analysis  

Comparison of Next-Generation Sequencing Versus Culture-Based Tests for Sepsis Pathogens Detection in the I...

DOI :10.12659/CPRM.938643

Clin Prac Rev Met 2023; 10:e938643

07 Mar 2023 : Database Analysis  

Visual Analysis of Research Trends and Hotspots in Traditional Chinese Medicine-Based Treatment of Chronic ...

DOI :10.12659/CPRM.939445

Clin Prac Rev Met 2023; 10:e939445

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Clinical Practice Review and Meta-Analysis eISSN: 2688-6650
Clinical Practice Review and Meta-Analysis eISSN: 2688-6650